investment Newsroom

Massive Bio plans acquisitions with Series B round

Massive Bio, a New York-based company with an AI tool that matches cancer patients with clinical trials appropriate to their cancer diagnosis, is planning bolt-on acquisitions following a Series B round likely to raise between USD 25m–USD 30m, co-founder and CEO Selin Kurnaz said. The health-tech company recently raised a

Read More »

The World’s Oldest Corporate Incubator

LONDON, UK 24th JANUARY 2023 – LettsGroup unlocks repeat innovation methodologies out of a historical family business model – the first of its kind. LettsGroup, the family-run branded venture group, has become the first to crack the code to repeat innovation, following the release of the 3rd edition of the

Read More »

The World’s Oldest Corporate Incubator

LONDON, UK 24th JANUARY 2023 – LettsGroup unlocks repeat innovation methodologies out of a historical family business model – the first of its kind. LettsGroup, the family-run branded venture group, has become the first to crack the code to repeat innovation, following the release of the 3rd edition of the

Read More »

Lentitek secures £250k seed investment to commercialize enabling biotechnologies for advanced cancer treatments and gene therapies

  Edinburgh, UK – 30 May 2023 – Edinburgh based Lentitek Ltd (Lentitek), a developer of pioneering manufacturing technologies enabling economic delivery of advanced cell and gene therapies, announced today that it has secured £250,000 ($300,000 USD) in seed investment.  This investment will be deployed to further advance its technology

Read More »